Early Access — free while we kick the tires
EdgarHawk

Harter Ava

Chief Legal Officer

Officer

Latest: CLO selling · April 2026

4 filings analyzed · 1 company · Latest 2026-04-28

Companies

Company Buys Sells Direction
LAM RESEARCH CORP LRCX 2 6 Net selling

Activity

April 2026
2026-04-28 LAM RESEARCH CORP LRCX
medium
Sell
6,010 shares
$1,554,547
Significance 4/10

CLO Harter Ava sold 6,010 shares of LRCX at $258.66 for $1,554,546.60; post-sale holdings 53,205 shares.

Harter Ava, Chief Legal Officer, sold 6,010 shares (6.0K shares) at $258.66 on 2026-04-27, reducing her LRCX holdings by 10.1% to 53,205 shares. The sale occurred near the stock's 52-week high of $272.41, at a price only 7.8% below that peak, during a period of significant recent strength (30-day change: +18.8%, 90-day change: +4.9%). Her cross-ticker track record of 3 prior sells shows a 0.00% well-timed rate at the 90-day mark, indicating her previous sales did not precede declines; moreover, her 4 prior LRCX trades show mixed timing outcomes with only 1 of 3 prior sales well-timed historically. The company itself reports strong fundamentals with $5.8B quarterly revenue, $1.8B net income, and robust annual growth of 23.7%, though the stock's P/E of 46.87 reflects a premium valuation.

March 2026
2026-03-03 LAM RESEARCH CORP LRCX
medium
Sell
4,000 shares
$930,000
Significance 5/10

LRCX Chief Legal Officer Ava Harter sold 4,000 shares at $232.50 on 2026-03-02, now trading -12.9% below that price.

Ava Harter, Chief Legal Officer of LAM RESEARCH CORP, executed a sale of 4,000 shares at $232.50 on 2026-03-02, reducing holdings to 54,705 shares (54.7K shares). The stock currently trades at $217.27, down 12.9% from the transaction price, and is -6.9% over the past 30 days despite a strong 90-day recovery of +36.0%. Across her prior LRCX trades, Harter has completed 2 prior sells and 1 buy; her same-ticker sell history shows both prior sales were followed by 90-day gains (+38.4% each), making them poorly timed exits. The company reports strong fundamentals with $5.3B quarterly revenue, 23.7% annual growth, and a P/E of 43.63, suggesting valuation context rather than earnings weakness may be driving recent price weakness. Without a FLAG note indicating scheduled trading constraints, this sale occurs in a volatile period where the insider's transaction price has proven higher than the current market level.

October 2025
2025-10-28 LAM RESEARCH CORP LRCX
medium
Sell
9,010 shares
$1,418,775
Significance 5/10

Harter Ava (Chief Legal Officer) sold 9,010 shares at $157.46–$157.48 for $1,418,774.60

Harter Ava, Chief Legal Officer of Lam Research Corp, executed 2 separate sales totaling 9,010 shares for $1,418,774.60 at prices of $157.48 and $157.46 on 2025-10-27, reducing her holdings by 13.7% to 56,786 shares post-transaction. The sale occurred near the stock's 52-week high of $156.90, with LRCX trading at $155.62 currently and up 21.3% over the past 30 days and 57.0% over 90 days. Harter's cross-ticker track record shows 1 prior buy with a 90-day return of +54.2%, and her single prior transaction at LRCX (a buy on 2025-04-08) also posted a 90-day return of +54.2%, indicating her historical buy timing has tracked market strength. This sale represents a material reduction in a significant personal position by a C-suite officer during a period of strong stock momentum.

August 2025
2025-08-06 LAM RESEARCH CORP LRCX
low
Buy
9 shares
$602
Significance 2/10

Chief Legal Officer Harter Ava purchased 9 shares of LRCX at $63.66; minimal addition to 59.8K share position.

Harter Ava, Chief Legal Officer of Lam Research, purchased 9 shares at $63.66 on 2025-04-08, increasing her holdings from 59,777 to 59,786 shares—a net change of +0.0% relative to her pre-transaction position. The transaction value of $601.91 is immaterial in absolute terms and represents a negligible addition to her existing stake. At the current price of $95.94, the stock trades below its 52-week high of $101.74 by 5.7%, but this single-digit share purchase provides limited signal about conviction or portfolio intent, particularly given the company's substantial scale ($4.7B quarterly revenue, $122.7B market cap) and the transaction's de minimis magnitude.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access